AXYS Pharmaceuticals Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AXYS Pharmaceuticals Inc.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tonyt who started this subject	9/15/2000 3:16:34 PM
From: nigel bates	of 455

Help wanted .... suggestions welcomed.... biz.yahoo.com Sept. 15, 2000-- Axys Pharmaceuticals, Inc. (Nasdaq:AXPH - news) announced today that John Walker, current CEO and Chairman, has informed the Board of Directors that he intends to step down from his position as CEO for family reasons. Walker indicated that he will remain an active Chairman of the Axys Board of Directors and would continue in both roles as Chairman and Chief Executive Officer until a successor is named. The Board noted that it had reluctantly accepted Walker's decision and retained Korn/Ferry International to recruit a successor who would hold the position of President and Chief Executive Officer. According to Walker, ``Axys has recently made significant progress in its collaborative research and proprietary oncology portfolios. Equally as important, we have taken several significant steps toward securing a financial foundation for the company that is stronger than it has been at any other time in its history. Furthermore, we have attracted several new executives to key positions in medicinal chemistry, finance and business development. Clearly, we are at a point where we can see a number of drug candidates advancing toward commercialization...

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next